AI assistant
Inogen Inc — Director's Dealing 2017
Feb 14, 2017
33625_dirs_2017-02-14_4e1cc800-5caa-4281-8025-664d4b896561.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2017-02-10
Reporting Person: Bauerlein Alison (EVP, Finance, & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-02-10 | Common Stock | S | 5956 | $67.0984 | Disposed | 29043 | Direct |
| 2017-02-10 | Common Stock | S | 710 | $67.6123 | Disposed | 28333 | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2016.
F2: Represents the weighted average share price of an aggregate total of 5956 shares sold in the price range of $66.47 to $67.31 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Represents the weighted average share price of an aggregate total of 710 shares sold in the price range of $67.47 to $67.67 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.